Gabriela Gruia - Net Worth and Insider Trading

Over the past 18 months, Gabriela Gruia made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Gabriela Gruia made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net purchase of 15,000 shares made by Barbara Klencke , and a net sale of 164,686 shares made by Zoran Zdraveski .

In summary, during the past 3 months, insiders sold 164,686 shares of TScan Therapeutics Inc (TCRX) in total and bought 10,000 shares, with a net sale of 154,686 shares. During the past 18 months, 190,086 shares of TScan Therapeutics Inc (TCRX) were sold and 82,027 shares were bought by its insiders, resulting in a net sale of 108,059 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Gabriela Gruia made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .

In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.